Sculptor Capital’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50,040
| Closed | -$76.3K | – | 327 |
|
|
2024
Q1 | $76.3K | Hold |
50,040
| – | – | ﹤0.01% | 176 |
|
|
2023
Q4 | $4.37K | Hold |
50,040
| – | – | ﹤0.01% | 265 |
|
|
2023
Q3 | $8K | Sell |
50,040
-13,226
| -21% | -$2.12K | ﹤0.01% | 286 |
|
|
2023
Q2 | $5.38K | Sell |
63,266
-2,400
| -4% | -$204 | ﹤0.01% | 332 |
|
|
2023
Q1 | $4.3K | Hold |
65,666
| – | – | ﹤0.01% | 442 |
|
|
2022
Q4 | $2.46K | Sell |
65,666
-1,000
| -2% | -$37 | ﹤0.01% | 666 |
|
|
2022
Q3 | $5K | Hold |
66,666
| – | – | ﹤0.01% | 933 |
|
|
2022
Q2 | $11K | Hold |
66,666
| – | – | ﹤0.01% | 977 |
|
|
2022
Q1 | $21K | Buy |
66,666
+16,666
| +33% | +$5.25K | ﹤0.01% | 1039 |
|
|
2021
Q4 | $26K | Hold |
50,000
| – | – | ﹤0.01% | 985 |
|
|
2021
Q3 | $29K | Hold |
50,000
| – | – | ﹤0.01% | 805 |
|
|
2021
Q2 | $51K | Buy |
+50,000
| New | +$51K | ﹤0.01% | 770 |
|